CNI 2000

InnoCare Pharma's ICP-488 Completes First Patient Dosing in Phase II Trial for Cutaneous Lupus

Cambridge Industries Discovers Strong Optical Module Demand, Advances Capacity Expansion and Supply Chain Security

InnoCare's ICP-054 Completes First Patient Enrollment

Euletek Partners with Google on GPU Power Supply Projects for Computing Equipment

Oultong Announces 2025 Data Center Power Business Targets and 2026 Revenue Growth Goals

Tongding Internet Publishes Stock Abnormal Movement Notice: Uncertainty in Fiber Prices and Impact on Performance

Chongqing Bank Achieves Continuous Double Growth in Revenue and Profit for Nine Quarters

Nocile Jianhua's TYK2 Inhibitor Approved for Phase II Clinical Trials in Treating Sjogren's Syndrome

Nocia Health's Innovative Drug ICP-B208 Approved for Clinical Trials

Insys Intelligence and ZhaoYan New Drug Sign Strategic Cooperation Agreement

Chongqing Bank Achieves Growth Through Cost Reduction in Liabilities

TDii released FY2026 Q1 earnings on April 29 During-Market (BJT), actual revenue CNY 1.064 B, actual EPS CNY 0.0417

Swancor Advanced Materials released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 417.94 M, actual EPS CNY -0.1

SPIC released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 2.475 B, actual EPS CNY 0.09

SEICHITECH released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 332.88 M, actual EPS CNY 0.15

Yunnan Germanium released FY2026 Q1 earnings on April 29 After-Market BJT, actual revenue CNY 288.87 M, actual EPS CNY 0.014

FORTUNE PRECISION released FY2026 Q1 earnings on April 29 During-Market (BJT), actual revenue CNY 1.043 B, actual EPS CNY 0.19

JPT released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 660.86 M, actual EPS CNY 1.03

CFMEE released FY2026 Q1 earnings on April 29 During-Market (BJT), actual revenue CNY 514.72 M (forecast CNY 408.08 M), actual EPS CNY 0.82 (forecast CNY 0.6)

Hongda Co., Ltd. released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 734.75 M, actual EPS CNY -0.0128

000016

399303

512100

<p>Since the beginning of 2026, the A-share market has seen high trading activity, but the performance of major stock indices has been mixed. The CSI 500 Index has risen by more than 15%, the CSI 1000 and CNI 2000 indices have increased by over 10%, while the SSE 50 Index has only slightly risen by 0.97%, and the CSI 300 Index has increased by 1.90%. The "scissors gap" between different indices continues to widen, and private equity firms are intensifying their practice of "offensive and defensive balance techniques."</p>

Wallstreetcn

SSE 50

China Southern CSI 1000 ETF

China Southern CSI 500 ETF

中证1000

CSI 500

ChinaAMC China 50 ETF

Huatai-PB CSI 300 ETF

CSI 300

Harvest CSI 500 ETF

Harvest SZSE SME-ChiNext Composite 300 ETF

The gap between stock index spreads continues to widen, and private equity firms are intensifying their practice of "offensive and defensive balance techniques."

CNI 2000(399303.SZ)

The gap between stock index spreads continues to widen, and private equity firms are intensifying their practice of "offensive and defensive balance techniques."